Cancer treatment developer Nuvalent (NUVL) is soaring after news that GSK is acquiring the company for $10.6 billion ...
It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and ...
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
Kyverna Therapeutics operates as a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases. Its lead product candidate, KYV-101, is a CAR ...
SolarWinds Q1 revenue up 4% to $193.31M, topping forecasts; adjusted EPS of $0.29 beats $0.22 estimate. Subscription revenue jumps 26.5% to $68.76M; adjusted EBITDA margin rises sharply by 600 bps to ...
Apple stock held gains Monday afternoon as Chief Executive Tim Cook kicked off his 15th Worldwide Developers Conference. The ...
Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results